Acknowledgement to Referees

Dear Reader,

As we reach the final issue of Targeted Oncology for 2019, we wish to reflect on another successful year’s achievements, and to thank all those who have contributed their time and effort to guarantee the high quality of our content.

Over 70 articles have been published; the most popular of these, in terms of downloads from SpringerLink, have been:

• Maximilian J. Hochmair et al. Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib

• Michael Moran et al. Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials Data

• Sarah Sammons et al. Fulvestrant-Based Combination Therapy for Second-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer

• Chang Liu et al. Crizotinib in Chinese Patients with ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer in Routine Clinical Practice

• Neal Shore et al. Evaluation of Clinically Relevant Drug–Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial

• Anna Buder et al. EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR

• Maja J. A. de Jonge et al. Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies

• Xiaonan Hong et al. Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T cell Lymphoma: A Single-arm, Multicenter Study

• Toshihiko Doi et al. Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors

• Y. Louise Wan et al. Combination Treatment with an Antibody–Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer

In the year from October 2018 to September 2019, articles from the journal were downloaded more than 83,000 times in total.

The quality of articles published in the journal is also reflected in its most recent impact factor (3.683). Targeted Oncology is currently ranked 80th in the ‘Oncology’ category (of 230 journals).

We thank the authors who have contributed articles to Targeted Oncology over the course of 2019. The skill and dedication of all authors are critical to the continued publication of the journal. The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for Targeted Oncology in the last 12 months:

Armina Abbasi, USA

Alfredo Addeo, Switzerland

Neeraj Agarwal, USA

Roberta Alfieri, Italy

Rodabe N. Amaria, USA

Jennifer E. Amengual, USA

Ravindran Ankathil, Malaysia

Thomas Aparicio, France

Xavier Armoiry, France

Arjun Balar, USA

Judith Balmaña, Spain

Malgorzata Banys-Paluchowski, Germany

Pedro C. Barata, USA

Jorge Barriuso, UK

Joshua Bauml, USA

Lyudmila Bazhenova, USA

Alain Beck, France

Tanios Bekaii-Saab, USA

Kara Bernstein, USA

Benoit Beuselinck, Belgium

Mehmet A. Bilen, USA

James S. Blachly, USA

Jean-Frédéric Blanc, France

Romain Boidot, France

Isaac A., Bowman, USA

Oktay Bozkurt, Turkey

Roman C. Brands, Germany

Marc J. Braunstein, USA

Adam M. Brufsky, USA

Alfredo Budillon, Italy

Olivier Bylicki, France

Jason E. Cain, Australia

Diego F. Calvisi, Italy

Andrés Felipe Cardona, Colombia

Anna Chalmers, USA

Nazia Chaudhuri, UK

Zhong Chen, USA

Manuel Cobo, Spain

Vincenzo Coppola, USA

Andrew Craig, USA

Mihaela Cristea, USA

Satya Das, USA

Maaike de Boer, The Netherlands

Ugo De Giorgi, Italy

Elena De Mattia, Italy

Luigi De Petris, Sweden

Marc Denis, France

Giovan Giuseppe Di Costanzo, Italy

Vincenzo Di Nunno, Italy

Rodrigo Dienstmann, Spain

Ricardo Díez Valle, Spain

Frede Donskov, Denmark

Andrew Donson, USA

Stella D’Oronzo, Italy

Jan Dürig, Germany

Michael Duruisseaux, France

Julien Edeline, France

Takanori Eguchi, Japan

Toby Eyre, UK

Martin Faehling, Germany

Sabrina Falkowski, France

Simone Ferrero, Italy

Alex Friedlaender, Switzerland

Junji Furuse, Japan

Timo Gaiser, Germany

Enrique Gallardo, Spain

Pere Gascon, Spain

Yubin Ge, USA

Anja Gesierich, Germany

Mark Geyer, USA

Salah Ghabri, France

Riccardo Giampieri, Italy

Sharlene Gill, Canada

Yasushi Goto, Japan

Frank Griesinger, Germany

Marine Gross-Goupil, France

Alexander David Guminski, Australia

Robin Guo, USA

Gopal Gupta, USA

Kilian Gust, Austria

David Guttery, UK

Andrew W. Hahn, USA

Balazs Halmos, USA

Baohui Han, China

Jun Hanaoka, Japan

Todd Hankinson, USA

Kevin Hay, USA

Isabel Heidegger, Germany

Judith Heinz, Germany

Cinta Hierro, Spain

Maximilian J. Hochmair, Austria

Sarah A. Holstein, USA

Florian Hucke, Austria

Evgeny Imyanitov, The Russian Federation

Hiroki Ishihara, Japan

Hiroji Iwata, Japan

Christian Jackisch, Germany

William Jacot, France

Joon Jeong, Republic of Korea

Xu-Rong Jiang, USA

Solene-Florence Kammerer-Jacquet, France

Nobuhiro Kanaji, Japan

Michalis V. Karamouzis, Greece

Kikuya Kato, Japan

Dermot Kelleher, Canada

Melin J. Khandekar, USA

Kyoung-Mee Kim, Republic of Korea

Sang-We Kim, Republic of Korea

Heinz-Josef Klümpen, The Netherlands

Hans-Christian Kolberg, Germany

Andreas Kolk, Germany

Tsunenori Kondo, Japan

Olga Kondrashova, Australia

Abhijeet Kumar, USA

Igor Latorzeff, France

Michael Lauseker, Germany

Xiuning Le, USA

Konstantinos Leventakos, USA

Vasilios Liapis, Australia

Chia-Chi Lin, Taiwan

Herbert H. Loong, Hong Kong

Jonathan Loree, Canada

Rimas Vincas Lukas, USA

Shinichi Makita, Japan

Maleki Maleki Vareki, Canada

David Malka, France

Gal Markel, Israel

Maurie Markman, USA

Federica Marmorino, Italy

Benjamin Louis Maughan, USA

Kelly Elizabeth McCann, USA

Carlo Messina, Italy

Yasuhiro Miki, Japan

Veronica Mollica, Italy

Alessandro Morabito, Italy

Aiko Nagayama, USA

Masaki Nakamura, Japan

Günter Niegisch, Germany

Kaname Nosaki, Japan

Seiichi Obake, Japan

In‐Jae Oh, Republic of Korea

Egbert Oosterwijk, The Netherlands

Malte Ottenhausen, Germany

L’Houcine Ouafik, France

John Pagel, USA

Tejas Patil, USA

Piers Patten, UK

Markus Peck-Radosavljevic, Austria

Maurice Perol, France

Eric Pichon, France

Michael J. Pishvaian, USA

Noam Pondé, Brazil

Jochen Prehn, Ireland

Rebecca Previs, USA

Andrew Protheroe, UK

Fabio Puglisi, Italy

Angel Qin, USA

Jeffrey Raizer, USA

Radhakrishnan Ramchandren, USA

Andrew Redfern, Australia

A.K. Reyners, The Netherlands

Jin Kyung Rho, Republic of Korea

Lorenza Rimassa, Italy

Ilaria Roato, Italy

Melanie Royce, USA

Felix Sahm, Germany

Yoshinobu Saito, Japan

Sarah Sammons, USA

Eric Santoni-Rugiu, Denmark

Jorge Santos-Juanes, Spain

Andrea Sartore-Bianchi, Italy

Robert Satcher, USA

Christine Dorothee Schmeitz, Germany

Manuela Schmidinger, Austria

David Alan Schoenfeld, USA

Gerty Schreibelt, The Netherlands

Martin Scurr, UK

John Francis Seymour, Australia

Danielle Shafer, USA

Jian Shi, USA

Hiroshi Soda, Japan

Ross A. Soo, Singapore

Francesca Spada, Italy

Srikala Sridhar, Canada

Justin Stebbing, UK

Cristina Suárez, Spain

Nora Sundahl, Belgium

Haruhiko Takeda, Japan

Daniel Taussky, Canada

Cristina Teixidó, Spain

Elisa Ten Hacken, USA

Tomohiro Terada, Japan

Raoul Tibes, USA

Sandar Tin Tin, New Zealand

Abhishek Tripathi, USA

Christopher C.J. Twelves, UK

Ulka Vaishampayan, USA

Michiel van der Heijden, The Netherlands

Anthonie J. van der Wekken, The Netherlands

Nielka van Erp, The Netherlands

Guy van Hazel, Australia

Meike Vogler, Germany

Jialei Wang, China

Yinghong Wang, USA

Andrew H. Wei, Australia

Marcel Wiesweg, Germany

Hirohito Yamaguchi, Qatar

Toshimitsu Yamaoka, Japan

Jie Yang, France

Changhoon Yoo, Republic of Korea

Tatsuya Yoshida, Japan

Ti Zhang, China

Yongchang Zhang, China

Caicun Zhou, China

In addition, we would like to thank the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:

James O. Armitage, Omaha, NE, USA

James R. Berenson, West Hollywood, CA, USA

Jean-Yves Blay, Lyon, France

Tomas Buchler, Prague, Czech Republic

Ann-Lii Cheng, Taipei, Taiwan

Fortunato Ciardiello, Napoli, Italy

Jayesh Desai, Melbourne, Australia

Sandrine Faivre, Clichy,France

Masahiro M. Fukuoka, Osaka, Japan

Giuseppe Giaccone, Washington, DC, USA

Petros Grivas, Seattle, WA, USA

Gabriel G.N. Hortobagyi, Houston, TX, USA

V. Craig Jordan, Houston, TX, USA

John M. Kirkwood, Pittsburgh, PA, USA

Heinz-Josef Lenz, Los Angeles, CA, USA

Raymond Liang, Hong Kong

Teresa Macarulla, Barcelona, Spain

William P. McGuire, Richmond, VA, USA

Mark J. McKeage, Auckland, New Zealand

Alain Mita, Los Angeles, CA, USA

Monica Mita, Los Angeles, CA, USA

Jean-François Morère, Paris-Nord, France

Athanasios G. Papavassiliou, Athens, Greece

Solange Peters, Lausanne, Switzerland

Camillo C. Porta, Pavia, Italy

Timothy Jay Price, Adelaide, Australia

Shukui Qin, Nanjing, China

Eric Raymond, Paris, France

Noemí Reguart, Barcelona, Spain

Olivier Rixe, Santa Fe, NM, USA

Helen Rizos, North Ryde, Australia

Christian Rolfo, Baltimore, MD, USA

Hans-Joachim Schmoll, Halle, Germany

Nicole A. Shonka, Omaha, NE, USA

Denis Soulières, Montréal, Canada

Josep Tabernero, Barcelona, Spain

Giampaolo Tortora, Verona, Italy

Eric Van Cutsem, Leuven, Belgium

John Eu Li Wong, Singapore

We do hope that you have found the articles published throughout the year in Targeted Oncology to be interesting and informative. The editorial schedule for 2020 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year.

With best wishes,

Martin Chopra

Editor

Targeted Oncology